NCT05273827View on ClinicalTrials.gov

Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium

CompletedOBSERVATIONAL
Enrollment

81

Participants

Timeline

Start Date

March 22, 2022

Primary Completion Date

December 20, 2023

Study Completion Date

January 2, 2024

Conditions
ImmunotherapyAnalgesiaNSCLCDelirium
Interventions
DRUG

neoadjuvant immunotherapy

Anti-PD-1 antibody was added to the conventional neoadjuvant chemotherapy.

DRUG

Neoadjuvant chemotherapy

Cis-platinum combined with paclitaxel or pemetrexed

Trial Locations (3)

300060

Tianjin Medical University Cancer Institute and Hospital, Tianjin

Unknown

Tianjin Chest Hospital, Tianjin

Tianjin Medical University General Hospital, Tianjin

All Listed Sponsors
collaborator

Tianjin Medical University General Hospital

OTHER

collaborator

Tianjin Chest Hospital

OTHER

lead

Tianjin Medical University Cancer Institute and Hospital

OTHER